查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030年全球角膜植入物市场
市场调查报告书
商品编码
1296887

2023-2030年全球角膜植入物市场

Global Corneal Implants Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

角膜植入物用于外科手术，在手术中用角膜组织替代眼睛的角膜。能够抑制全球角膜植入物市场的主要因素包括人眼对由异体材料组成的人工角膜的排斥概率增加。此外，全球大约有1000万人患有角膜盲症。因此，角膜盲症发病率的上升以及人类角膜供体的缺乏是在预测期内推动角膜移植市场增长的主要因素之一。

分段展望

角膜植入物市场根据组织类型、角膜疾病和终端用户进行划分。根据组织类型，市场被划分为人工角膜和人类供体。根据角膜疾病，市场被划分为真菌性角膜炎、Fuchs营养不良症和角膜炎。根据终端用户，市场被划分为医院、眼科诊所和非住院手术中心（ASC）。

人工角膜领域将获得显著的份额

目录

第一章：报告摘要

  • 当前行业分析和增长潜力展望
  • 研究方法和工具
  • 市场细分
    • 按领域划分
    • 按地区

第二章：市场概述和洞察力

  • 报告的范围
  • 分析师的洞察力和当前的市场趋势
    • 主要发现
    • 建议
    • 总结

第三章：竞争格局

  • 主要公司分析
  • Company
    • 概述
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • 关键战略分析

第四章：市场细分

  • 按组织类型分類的全球角膜植入物市场
    • 人工角膜
    • 人类捐献者
  • 按角膜疾病分類的全球角膜植入物市场
    • 真菌性角膜炎
    • 富克斯营养不良症
    • 角膜炎
  • 按终端用户分類的全球角膜植入物市场
    • 医院
    • 眼科诊所
    • 非住院手术中心(ASC)

第五章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第六章：公司简介

  • AcuFocus, Inc.
  • Addition Technology, Inc., (A Company of AJL Ophthalmic, S.A.)
  • Adverum Biotechnologies Inc.
  • Alcon (A Division of Novartis AG)
  • Astellas Pharma US, Inc.
  • Bausch & Lomb Inc.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Cornea Bioscience
  • CryoLife Inc.
  • F. Hoffmann-La Roche Ltd.
  • Keramed Inc.
  • Medtronic Plc
  • Pfizer Inc.
  • Presbia PLC
Product Code: OMR2027338

Global corneal implants market is expected to grow at a CAGR of 6.3% during the forecast period. The market is growing attributed to rising in the incidences of corneal blindness along with the lack of human cornea donors. The other factor that will propel the growth of corneal transplant surgery is the increasing aging population that demands corneal transplants. According to the Eye Bank Association of America, there were approximately 85,411 cornea implants were done alone in America in 2018. Whereas, higher prices of surgeries restrain the market growth, therefore the adoption of this surgery is quite low in developing countries which will also deter the growth of the market over the forecast period.

The corneal implant is used in surgical procedures in which the eye cornea is replaced by corneal tissues. The major factor that can restrain the global cornea implant market includes the increased probability of rejection of artificial cornea made up of alloplastic material by the human eye. In addition, approximately 10 million people across the globe suffer from corneal blindness. Thus, the rise in the incidences of corneal blindness along with the lack of human cornea donors is among the primary factor that fuels the growth of the cornea implant market during the forecast period.

Segmental Outlook

The corneal implant market is sectioned based on tissue type, corneal disease, and end-user. Based on the tissue type, the market is segmented into artificial cornea and human donors. Based on the corneal disease, the market is segmented into fungal keratitis, Fuchs dystrophy, and keratoconus. Based on the end-user, the market is segmented into hospitals, eye clinics, and ambulatory surgical centers (ASC).

Artificial Cornea Segment to Register Notable Share

Based on the type, the artificial cornea segment registers a notable share in the global corneal implant market. This is attributed to increasing cases related to eye diseases. The factor that majorly contributes to the market is the shortage of eye and tissue banking along with a decrease in cornea donors across the globe. Synthetic cornea implants and biosynthetic cornea implants are the two most common types of artificial cornea implants. Whereas, the factor that challenges the artificial cornea segment is the high transplantation costs and extra and preventive measures that should be taken for the long term.

Regional Outlooks

The global corneal implants market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Europe market is anticipated to cater to a prominent growth over the forecast period. However, the Asia-Pacific region is projected to experience considerable growth in the Corneal Implants market.

The North American Region is anticipated to Hold a Significant Share in the Global Corneal Implants Market

Among these regions, the North American region is anticipated to account for a significant share of the Corneal Implants market during the forecast period. The growth of the corneal implants market in the region is primarily driven by factors such as the increased number of eye-related issues and vision problems in the region. According to the Eye Bank Association of America, the bank reported approximately 133,576 total tissue recoveries from 68,102 donors in 2018. Thus, these numbers of eye transplants are likely to provide opportunities for market growth. In addition, the frequent development of the products along with the improved healthcare infrastructure of the region contributes to the growth of the corneal implants market across the region.

Market Players Outlook

The prominent players operating in the global corneal implants market include Bayer AG, Medtronic Plc, F. Hoffmann-La Roche Ltd., Pfizer Inc. Bausch & Lomb Inc., PowerVision Inc., Presbia PLC, Regeneron Pharmaceuticals Inc. among others. These are the key companies providing various solutions for novel and advanced corneal implants. The corneal implant manufacturers are adopting various strategies such as new product launches and approvals, mergers and acquisitions, partnerships and collaborations, and many others to thrive in a competitive environment in the market. For instance, In June 2016, the US FDA approved the Raindrop Near Vision Inlay, for the improvement of near vision is presbyopic. Further, in April 2015, the US FDA approved the Kamra Corneal Inlay, the first small aperture corneal implantable device for the correction of near vision in patients who have not had cataract surgery.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Company
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Corneal Implants Market by Tissue Type
    • 4.1.1. Artificial Cornea
    • 4.1.2. Human Donor
  • 4.2. Global Corneal Implants Market by Corneal Disease
    • 4.2.1. Fungal keratitis
    • 4.2.2. Fuchs Dystrophy
    • 4.2.3. Keratoconus
  • 4.3. Global Corneal Implants Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Eye Clinics
    • 4.3.3. Ambulatory Surgical Centers (ASC)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AcuFocus, Inc.
  • 6.2. Addition Technology, Inc., (A Company of AJL Ophthalmic, S.A.)
  • 6.3. Adverum Biotechnologies Inc.
  • 6.4. Alcon (A Division of Novartis AG)
  • 6.5. Astellas Pharma US, Inc.
  • 6.6. Bausch & Lomb Inc.
  • 6.7. Bayer AG
  • 6.8. Boehringer Ingelheim GmbH
  • 6.9. Cornea Bioscience
  • 6.10. CryoLife Inc.
  • 6.11. F. Hoffmann-La Roche Ltd.
  • 6.12. Keramed Inc.
  • 6.13. Medtronic Plc
  • 6.14. Pfizer Inc.
  • 6.15. Presbia PLC

LIST OF TABLES

  • 1. GLOBAL CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY TISSUE TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL ARTIFICIAL CORNEA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL HUMAN DONOR MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY CORNEAL DISEASE, 2022-2030 ($ MILLION)
  • 5. GLOBAL FUNGAL KERATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL FUCHS DYSTROPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL KERATOCONUS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 9. GLOBAL CORNEAL IMPLANTS IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL CORNEAL IMPLANTS IN EYE CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL CORNEAL IMPLANTS IN ASC MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY TISSUE TYPE, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY CORNEAL DISEASE, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 17. EUROPEAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. EUROPEAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY TISSUE TYPE, 2022-2030 ($ MILLION)
  • 19. EUROPEAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY CORNEAL DISEASE, 2022-2030 ($ MILLION)
  • 20. EUROPEAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 21. ASIA-PACIFIC CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY TISSUE TYPE, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY CORNEAL DISEASE, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY TISSUE TYPE, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY CORNEAL DISEASE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CORNEAL IMPLANTS MARKET SHARE BY TISSUE TYPE, 2023 VS 2030 (%)
  • 2. GLOBAL CORNEAL IMPLANTS MARKET SHARE BY CORNEAL DISEASE, 2023 VS 2030 (%)
  • 3. GLOBAL CORNEAL IMPLANTS MARKET SHARE BY END-USER, 2023 VS 2030 (%)
  • 4. GLOBAL CORNEAL IMPLANTS MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 5. GLOBAL ARTIFICIAL CORNEA MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 6. GLOBAL HUMAN DONOR MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 7. GLOBAL FUNGAL KERATITIS MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 8. GLOBAL FUCHS DYSTROPHY MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 9. GLOBAL KERATOCONUS MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 10. GLOBAL CORNEAL IMPLANTS IN HOSPITALS MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 11. GLOBAL CORNEAL IMPLANTS IN EYE CLINICS MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 12. GLOBAL CORNEAL IMPLANTS IN ASC MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 13. US CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. CANADA CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. UK CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. FRANCE CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. GERMANY CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. ITALY CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. SPAIN CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ROE CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. INDIA CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. CHINA CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. JAPAN CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)